| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |